KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Other financing activities (2016 - 2026)

Medtronic's Other financing activities history spans 12 years, with the latest figure at -$5.0 million for Q1 2026.

  • For Q1 2026, Other financing activities fell 103.12% year-over-year to -$5.0 million; the TTM value through Jan 2026 reached -$220.0 million, down 260.58%, while the annual FY2025 figure was -$184.0 million, 6033.33% down from the prior year.
  • Other financing activities for Q1 2026 was -$5.0 million at Medtronic, roughly flat from -$5.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at $273.0 million in Q3 2022 and bottomed at -$719.0 million in Q1 2023.
  • The 5-year median for Other financing activities is -$5.0 million (2025), against an average of -$19.2 million.
  • The largest annual shift saw Other financing activities surged 6925.0% in 2022 before it plummeted 11883.33% in 2023.
  • A 5-year view of Other financing activities shows it stood at $170.0 million in 2022, then dropped by 5.29% to $161.0 million in 2023, then tumbled by 130.43% to -$49.0 million in 2024, then surged by 89.8% to -$5.0 million in 2025, then changed by 0.0% to -$5.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Other financing activities are -$5.0 million (Q1 2026), -$5.0 million (Q4 2025), and $70.0 million (Q3 2025).